fluspirilene has been researched along with Acute Confusional Senile Dementia in 2 studies
Fluspirilene: A long-acting injectable antipsychotic agent used for chronic schizophrenia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hajjo, R | 1 |
| Setola, V | 1 |
| Roth, BL | 1 |
| Tropsha, A | 1 |
| Ma, X | 1 |
| Mei, J | 1 |
| Gao, W | 1 |
| Xu, W | 1 |
| Ahmad, S | 1 |
| Ai, H | 1 |
2 other studies available for fluspirilene and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Chemocentric informatics approach to drug discovery: identification and experimental validation of selective estrogen receptor modulators as ligands of 5-hydroxytryptamine-6 receptors and as potential cognition enhancers.
Topics: Alzheimer Disease; Cell Line, Tumor; Cloning, Molecular; Cognition; Drug Discovery; Drug Evaluation, | 2012 |
Recognition of Aβ oligomer by LilrB2 acceptor: a tetracoordinated zipper mechanism.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Fluspirilene; Humans; Immunoglobulins; Membrane Glycoprote | 2022 |